A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.
Wong SF, Unger JM, Wade JL 3rd, Wagner LI, Lacouture ME, Humphries KC, Moseley A, Arnold K, Velasco MR Jr, Floyd JD, Esparaz BT, Barzi A, Lenz HJ, Koczywas M, Dakhil S, Burton GV, Fisch MJ, Henry NL, Hershman DL, Moinpour CM.
Wong SF, et al. Among authors: lenz hj.
J Patient Rep Outcomes. 2020 Jul 8;4(1):54. doi: 10.1186/s41687-020-00220-x.
J Patient Rep Outcomes. 2020.
PMID: 32642992
Free PMC article.